Fundraising FoxOncoDNA Group
2 known investors
Find your way into OncoDNA Group
Sign up to see every warm intro you have to OncoDNA Group
- Paths you didn't know you had: your email and LinkedIn already hold routes to the OncoDNA Group team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
OncoDNA develops next-generation sequencing (NGS) testing products and clinical interpretation solutions for precision oncology, including tissue and liquid biopsy assays for molecular tumour profiling. It serves oncology clinicians, diagnostic laboratories, and biopharma companies to support treatment selection and patient monitoring in cancer care.
Investors · 2
Frequently asked questions
- What does OncoDNA Group do?
- OncoDNA develops next-generation sequencing (NGS) testing products and clinical interpretation solutions for precision oncology, including tissue and liquid biopsy assays for molecular tumour profiling. It serves oncology clinicians, diagnostic laboratories, and biopharma companies to support treatment selection and patient monitoring in cancer care.
- Who are OncoDNA Group's investors?
- OncoDNA Group's investors include Inventures Investment Partners, Wallonie Entreprendre.